Structure-Based Optimization of Potent Pdk1 Inhibitors.
Angiolini, M., Banfi, P., Casale, E., Casuscelli, F., Fiorelli, C., Saccardo, M.B., Silvagni, M., Zuccotto, F.(2010) Bioorg Med Chem Lett 20: 4095
- PubMed: 20621725 
- DOI: https://doi.org/10.1016/j.bmcl.2010.05.070
- Primary Citation of Related Structures:  
2XCH, 2XCK - PubMed Abstract: 
In this Letter is described the structure-based design of potent dihydro-pyrazoloquinazolines as PDK1 inhibitors. Starting from low potency HTS hits with the aid of X-ray crystallography and modeling, a medicinal chemistry activity was carried out to improve potency versus PDK1 and selectivity versus CDK2 protein kinase.
Organizational Affiliation: 
Nerviano Medical Sciences Srl, Viale Pasteur 10, 20014 Nerviano, Milano, Italy. mauro.angiolini@nervianoms.com